Lee Hunter M.D., M.B.A. is a board-certified orthopaedic surgeon who specializes in surgery of the upper extremity particularly the elbow, wrist , and hand. Dr. Hunter founded Hunter Medical, LLC. in 2013 and serves as Chairman of the Board and as the Chief Innovation Officer. He holds multiple U. S. Patents, with multiple U. S. and international patent applications pending.
Dr. Hunter attended medical school at the University of Tennessee Center for the Health Sciences. He subsequently completed orthopaedic surgery residency at the Campbell Clinic. Dr. Hunter has served as a medical missionary in Zimbabwe and St. Lucia. He is a partner at the Mid Tennessee Bone and Joint Clinic in Columbia, Tennessee.
Dr. Hunter is driven by streamlining the OR process to make surgery more efficient, more predictable, and less costly.
Steven E. Simpson currently serves on the Board of Directors for Hunter Medical. Mr. Simpson is a founder and Managing Partner of Wheelhouse, LLC, a hands-on management firm developed specifically for companies seeking strong leadership to achieve demonstrable growth. Mr. Simpson has assumed leadership roles such as CEO for one of the portfolio companies, Currie Medical Specialties. Prior to founding Wheelhouse, Mr. Simpson served as the President and Chief Executive Officer of Spheris, Inc. In six years, Simpson led the company through three significant acquisitions and a profitable recapitalization that grew the company from a $17 million domestic-only medical transcription service provider with an earnings loss to a $200 million global clinical documentation technology and service provider with $34 million in EBITDA.
Before Spheris, Mr. Simpson was one of the lead executives who negotiated the $2.5 billion sale of Envoy from Quintiles Envoy Corporation to Healtheon/WebMD Corporation in the creation of the largest healthcare transaction company. He started his affiliation with these companies in 1998 as the Chief Sales and Marketing Officer for Quintiles Envoy. From there, he assumed the role of Chief Operating Officer and was one of three executives who made up the Office of the President. After the successful negotiation and sale of Envoy, Mr. Simpson became the President of the Transaction Services Division of WebMD. While in that role, the company grew from approximately $200 million to more than $500 million in revenue, through a combination of 14 acquisitions and organic growth that realized an estimated $100 million in synergies.
Scott S. Bowman currently serves on the Board of Directors for Hunter Medical. Mr. Bowman most recently has served as Currie Medical Specialties’ (CMS) Chief Operating Office and Chief Financial Officer providing oversight of all Financial and Operations areas of the company. He has spent the past two decades in company leadership roles working in both the public and private sectors with significant experience in corporate finance, mergers and acquisitions, company integrations, and back-office finance and accounting operations. Prior to joining CMS, Mr. Bowman served as VP Finance and Chief Accounting Officer of MedQuist Holdings, Inc, (subsequent to its acquisition of Spheris, Inc.), a $500 million revenue/ 14,000 employee public-company global provider of medical transcription services and technologies. In this prior role, he was responsible for global public and creditor/ analyst reporting (including SEC requirements), treasury operations, billing, payroll, and general accounting.
Prior to this, Bowman worked as an Audit Manager for Ernst and Young and Arthur Anderson. He is a licensed CPA, and holds a Master of Accountancy and a BS degree in Accounting from the University of Tennessee, Knoxville.